April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Cytochrome P450 Epoxygenase 2C8 Metabolites of ω3-Long-Chain Polyunsaturated Fatty Acids Increase Pathologic Neovascularization in Mouse Retina
Author Affiliations & Notes
  • Yan Gong
    Ophthalmology, Boston Children, Boston, MA
  • Zhuo Shao
    Ophthalmology, Boston Children, Boston, MA
  • Zhongjie Fu
    Ophthalmology, Boston Children, Boston, MA
  • Matthew Edin
    Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC
  • Lucy P Evans
    Ophthalmology, Boston Children, Boston, MA
  • Hannah H Bogardus
    Ophthalmology, Boston Children, Boston, MA
  • Katherine T Tian
    Ophthalmology, Boston Children, Boston, MA
  • Jing Chen
    Ophthalmology, Boston Children, Boston, MA
  • Darryl C Zeldin
    Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC
  • Lois Smith
    Ophthalmology, Boston Children, Boston, MA
  • Footnotes
    Commercial Relationships Yan Gong, None; Zhuo Shao, None; Zhongjie Fu, None; Matthew Edin, None; Lucy Evans, None; Hannah Bogardus, None; Katherine Tian, None; Jing Chen, None; Darryl Zeldin, None; Lois Smith, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5393. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yan Gong, Zhuo Shao, Zhongjie Fu, Matthew Edin, Lucy P Evans, Hannah H Bogardus, Katherine T Tian, Jing Chen, Darryl C Zeldin, Lois Smith; Cytochrome P450 Epoxygenase 2C8 Metabolites of ω3-Long-Chain Polyunsaturated Fatty Acids Increase Pathologic Neovascularization in Mouse Retina. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5393.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Pathologic neovascularization during oxygen-induced retinopathy (OIR) is suppressed by dietary ω3-long-chain polyunsaturated fatty acids (ω3LCPUFAs) through anti-angiogenic metabolites of cyclooxygenase and lipoxygenase. ω3LCPUFAs can also be metabolized by Cytochrome P450 epoxygenase 2C8 (CYP2C8), producing bioactive epoxides, which are inactivated by soluble epoxide hydrolase (sEH) to trans-dihydrodiols. The purpose of this study is to identify the effects of CYP2C8 and sEH, as well as their metabolites, on neovascularization in mouse retina.

Methods: The mouse model of OIR was used to investigate retinal neovascularization. Levels of CYP2C8 and sEH metabolites in plasma and retina were determined by liquid chromatography and tandem mass spectroscopy. The angiogenic role of CYP2C8 and its metabolites, as well as the angiogenic role of sEH, were evaluated in OIR and also corroborated in aortic ring assays from Tie2-driven-CYP2C8-overexpressing (Tie2-CYP2C8-Tg) and in Tie2-driven-sEH-overexpressing (Tie2-sEH-Tg) mice.

Results: CYP2C (expressed in monocytes/macrophages) is up-regulated in OIR while sEH is suppressed, resulting in an increased retinal epoxide:diol ratio. With a ω3LCPUFA-enriched diet, Tie2-CYP2C8-Tg mice show increased retinal neovascularization, associated with increased 19,20-EDP concentration in plasma and increased retinal epoxide:diol ratio. In Tie2-sEH-Tg mice, retinal neovascularization is increased, accompanied by decreased 19,20-EDP concentration in plasma and decreased retinal epoxide:diol ratio. Conditional overexpression of CYP2C8 or sEH in mice does not change normal retinal vascular development compared with their wild-type littermate controls.

Conclusions: Our results suggest that CYP2C metabolites of ω3LCPUFA promote pathologic angiogenesis in mouse retina. CYP2C8 is part of a novel lipid metabolic pathway influencing retinal neovascularization.

Keywords: 706 retinopathy of prematurity • 583 lipids • 700 retinal neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×